Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.
about
Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein FunctionBordetella pertussis: the intersection of genomics and pathobiologyNew Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge modelPolymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 yearsGenotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United KingdomImmunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussisEpitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes.Bordetella species are distinguished by patterns of substantial gene loss and host adaptation.Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine modelFactors contributing to pertussis resurgence.Bordetella pertussis strain variation and evolution postvaccination.Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchisepticaSignificant gene order and expression differences in Bordetella pertussis despite limited gene content variation.Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
P2860
Q27318916-6048CA68-F3CA-46A5-A52B-D147D41FE540Q30476000-BDEF2B7D-424E-49F6-ADF6-EE5F23F94614Q30994981-553C1BD9-3A28-475F-8AE8-B474C81EE52CQ33825728-7053E57B-A553-4D27-B079-8D89E79B2E66Q33974293-2D9CA724-FA24-485D-8DBD-4EEDC39F5199Q34008925-7A082430-FEBD-4E4B-9497-40E9FFDB28DFQ34126969-01AE03B4-F0C5-4FE3-BC3C-E3BEB89F778AQ34541373-CA8EE45E-AB5C-4D7F-B298-B6EEA562DFF4Q34759839-2B05DD90-FCF9-4285-AD31-214D764C49DCQ35140321-D7384540-0C68-4A4B-B92B-3DD2054214C7Q35155957-6A4B0785-C747-4E3F-80DF-FC96D0F36A38Q35220642-1E45E96F-0308-4CA6-AA8E-9CC275076596Q36239043-1E3CEA29-E2B0-4475-BBFD-D4E830F6038EQ36284571-8E81E431-23C2-4F8C-9775-364C166F4E1BQ36334703-CE578961-849D-4C7C-8B4B-0FC37364602CQ37174125-E4443168-44B7-4AAE-B908-569FEC9D7AA3Q37524032-C2B0915E-D8A8-408D-B2FF-5F95C9B6DB17Q37597352-7CFC4CFE-928B-4A9C-80E8-B95490233CC1Q37664578-D8B63092-BB62-4A83-B465-04B31CFB80B7Q37702699-1BA97BB5-100E-41CE-B258-193F48ABCD58Q38560702-D65987D4-1B71-4D8D-9000-33D8BE62A7B7Q39515019-EA16642D-36E4-4BD1-AE95-69EFEECA1724Q39520863-0D53BB7D-17E7-4427-83F5-7930FC9DF534Q43259915-81AA5370-C7F2-4203-AEFD-235AD26DC63FQ54627895-1AD51C50-9920-43DF-B2B7-AF5B1D5A57D8
P2860
Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@en
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@nl
type
label
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@en
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@nl
prefLabel
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@en
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@nl
P2093
P1433
P1476
Intranasal murine model of Bor ...... ricomponent acellular vaccine.
@en
P2093
Boursaux-Eude C
Carletti G
Thiberge S
P304
P356
10.1016/S0264-410X(99)00038-9
P407
P577
1999-06-01T00:00:00Z